Vx 001
Alternative Names: hTERT572Y/hTERT572; Human telomerase reverse transcriptase 572Y; TERT572Y; Vx-001; Vx-001/hTERTLatest Information Update: 16 Apr 2021
At a glance
- Originator Vaxon Biotech
- Class Cancer vaccines; Peptide vaccines; Peptides
- Mechanism of Action Immunostimulants; T lymphocyte stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Non-small cell lung cancer; Solid tumours
Most Recent Events
- 16 Apr 2021 No development reported - Phase-II for Non-small cell lung cancer (Inoperable/Unresectable) in Greece (SC)
- 16 Apr 2021 No development reported - Phase-II for Non-small cell lung cancer (Metastatic disease, Recurrent) in France (SC)
- 16 Apr 2021 No development reported - Phase-II for Non-small cell lung cancer (Metastatic disease, Recurrent) in Germany (SC)